Skip to main content

Table 3 Occurrence of secondary endpoints

From: Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance

Secondary Endpoints, n (%)

eMVO + (n = 74)

eMVO - (n = 33)

p-value

Death

3 (4.1)

1 (3.0)

.797

CV-death

2 (2.7)

1 (3.0)

.678

Re-infarction

9 (12.3)

2 (6.1)

.327

Re-CAG

23 (31.5)

8 (24.2)

.446

Ischemic symptoms

18 (24.7)

2 (6.1)

.023*

Stroke

1 (1.4)

0 (0.0)

.496

Atrial fibrillation

6 (8.2)

0 (0.0)

.090

Congestive heart failure

9 (12.3)

0 (0.0)

.035*

Hospitalisation

44 (60.3)

13 (39.4)

.046*

CV-hospitalisation

34 (46.6)

9 (28.1)

.077

SUM

49 (66.2)

14 (42.4)

.021*

* Chi-square p < 0.05

   
  1. Comparison of eMVO + and eMVO- patients according to the occurrence of the secondary endpoints (*p < 0.05). eMVO: early microvascular obstruction, CV: cardiovascular, CAG: coronary angiography.